Baxter working on swine flu vaccine

Specialty drug maker Baxter International Inc. will work with the World Health Organization to develop a vaccine that could stem an outbreak of a deadly swine flu strain in Mexico.

Baxter spokesman Christopher Bona said Saturday that the Deerfield-based company has asked the WHO for a sample of the flu strain.

He says Baxter has patented technology that allows the company to develop vaccines in half the time it usually takes -- about 13 weeks instead of 26.

There have been 20 confirmed deaths in Mexico of the swine flu, with nonfatal cases also confirmed in Kansas and California.

Humans don't have a natural immunity to swine flu strain that emerged in Mexico in March. Officials have warned the outbreak could become a global epidemic.